Kesler Norman & Wride LLC Has $769,000 Stake in CorVel Co. (NASDAQ:CRVL)

Kesler Norman & Wride LLC raised its holdings in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 295.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,904 shares of the business services provider's stock after acquiring an additional 5,158 shares during the quarter. Kesler Norman & Wride LLC's holdings in CorVel were worth $769,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of CRVL. Fifth Third Bancorp increased its stake in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock worth $36,000 after purchasing an additional 101 shares during the last quarter. Jones Financial Companies Lllp acquired a new stake in shares of CorVel in the fourth quarter worth $37,000. US Bancorp DE boosted its holdings in shares of CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider's stock worth $43,000 after buying an additional 266 shares during the period. GAMMA Investing LLC grew its stake in CorVel by 175.2% in the 4th quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock valued at $48,000 after buying an additional 275 shares during the last quarter. Finally, CIBC Private Wealth Group LLC lifted its position in CorVel by 300.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 480 shares of the business services provider's stock worth $53,000 after acquiring an additional 360 shares during the last quarter. 51.36% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analyst Ratings Changes

Separately, StockNews.com lowered shares of CorVel from a "buy" rating to a "hold" rating in a research report on Thursday, March 13th.

Insiders Place Their Bets

In related news, Director Steven J. Hamerslag sold 10,000 shares of CorVel stock in a transaction dated Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the sale, the director now directly owns 314,000 shares in the company, valued at $38,772,720. This trade represents a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brandon O'brien sold 1,523 shares of the firm's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total transaction of $182,089.88. Following the completion of the transaction, the chief financial officer now directly owns 17,142 shares in the company, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,200 shares of company stock valued at $3,824,115. 47.57% of the stock is currently owned by corporate insiders.

CorVel Stock Down 1.7 %

CorVel stock traded down $1.83 on Monday, hitting $108.68. The company's stock had a trading volume of 38,143 shares, compared to its average volume of 111,492. The firm has a market cap of $5.58 billion, a P/E ratio of 63.69 and a beta of 0.94. CorVel Co. has a one year low of $76.20 and a one year high of $128.61. The company has a fifty day moving average price of $112.27 and a 200-day moving average price of $114.86.

CorVel (NASDAQ:CRVL - Get Free Report) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.